TITLE:
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)

CONDITION:
Glaucoma, Open-Angle

INTERVENTION:
Travoprost

SUMMARY:

      The purpose of this study is to evaluate the safety and IOP-lowering efficacy of Travoprost
      (0.004%) compared to Latanoprost (0.005%) in patients with chronic open-angle glaucoma or
      ocular hypertension.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Adult patients of any race and either sex with open-angle glaucoma (with or without
        pigment dispersion or pseudoexfoliation component) or ocular hypertension.
      
